Molecular Biology Enzymes & Kits & Reagents Market by Type, Application, End-User

List of Tables

The Molecular Biology Enzymes & Kits & Reagents Market is projected to reach USD 42.02 billion by 2030 from USD 17.18 billion in 2022, at a CAGR of 11.82% during the forecast period.

Global Molecular Biology Enzymes & Kits & Reagents Market

KEY MARKET STATISTICS
Base Year Value [2022]	USD 17.18 billion
Estimated Year Value [2023]	USD 19.14 billion
Forecast Year Value [2030]	USD 42.02 billion
CAGR (%)	11.82%

Molecular Biology Enzymes & Kits & Reagents Market - IMG1

Market Segmentation & Coverage:

This research report analyzes various sub-markets, forecasts revenues, and examines emerging trends in each category to provide a comprehensive outlook on the Molecular Biology Enzymes & Kits & Reagents Market.

Based on Type, market is studied across Enzymes, Kits, and Reagents. The Enzymes is further studied across DNA Polymerases, Ligases, and Restriction Enzymes. The Kits is further studied across DNA Sequencing Kits, PCR Kits, and RNA Extraction Kits. The Reagents is further studied across Buffers, Dyes, Nucleotides, Primers, and Stains. The Reagents is projected to witness significant market share during forecast period.

Based on Application, market is studied across Drug Discovery & Development, Epigenetics, Polymerase Chain Reaction, and Sequencing. The Drug Discovery & Development is projected to witness significant market share during forecast period.

Based on End-User, market is studied across Academic & Research institutions, Diagnostic Centers, Hospitals, and Pharma & Biotech Companies. The Pharma & Biotech Companies is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Europe, Middle East & Africa is projected to witness significant market share during forecast period.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is an indispensable tool for assessing the Molecular Biology Enzymes & Kits & Reagents Market. It comprehensively evaluates vendors, analyzing key metrics related to Business Strategy and Product Satisfaction. This enables users to make informed decisions tailored to their specific needs. Through advanced analysis, vendors are categorized into four distinct quadrants, each representing a different level of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V). Be assured that this insightful framework empowers decision-makers to navigate the market with confidence.

Market Share Analysis:

The Market Share Analysis offers invaluable insights into the vendor landscape Molecular Biology Enzymes & Kits & Reagents Market. By evaluating their impact on overall revenue, customer base, and other key metrics, we provide companies with a comprehensive understanding of their performance and the competitive environment they confront. This analysis also uncovers the level of competition in terms of market share acquisition, fragmentation, dominance, and industry consolidation during the study period.

Key Company Profiles:

The report delves into recent significant developments in the Molecular Biology Enzymes & Kits & Reagents Market, highlighting leading vendors and their innovative profiles. These include ACROBiosystems Inc., Agilent Technologies, Inc., Bio Basic Inc., Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche Ltd., Fortis Life Sciences, Illumina, Inc., Jena Bioscience GmbH, Krishgen Biosystems, LGC Limited, Merck KGaA, Miltenyi Biotec B.V. & Co. KG, Molecular Biology Resources, Inc., New England Biolabs, Inc., PerkinElmer Inc., Promega Corporation, QIAGEN N.V., Rockland Immunochemicals, Inc., Sartorius AG, Takara Holdings Inc., Thermo Fisher Scientific Inc., and Zymo Research Corporation.

The report offers valuable insights on the following aspects:

1. Market Penetration: It provides comprehensive information about key players' market dynamics and offerings.

2. Market Development: In-depth analysis of emerging markets and penetration across mature market segments, highlighting lucrative opportunities.

3. Market Diversification: Detailed information about new product launches, untapped geographies, recent developments, and investments.

4. Competitive Assessment & Intelligence: Exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of leading players.

5. Product Development & Innovation: Intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast for the Molecular Biology Enzymes & Kits & Reagents Market?

2. Which products, segments, applications, and areas hold the highest investment potential in the Molecular Biology Enzymes & Kits & Reagents Market?

3. What is the competitive strategic window for identifying opportunities in the Molecular Biology Enzymes & Kits & Reagents Market?

4. What are the latest technology trends and regulatory frameworks in the Molecular Biology Enzymes & Kits & Reagents Market?

5. What is the market share of the leading vendors in the Molecular Biology Enzymes & Kits & Reagents Market?

6. Which modes and strategic moves are suitable for entering the Molecular Biology Enzymes & Kits & Reagents Market?

Product Code: MRR-521BAA36EAB0

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

4.1. Introduction
4.2. Molecular Biology Enzymes & Kits & Reagents Market, by Region

5. Market Insights

5.1. Market Dynamics
- 5.1.1. Drivers
  - 5.1.1.1. Increasing number of genome projects across the world
  - 5.1.1.2. Growing incidences of genetic disorders, metabolic diseases, and immune system disorders
  - 5.1.1.3. Rise in use of bioinformatics and computational tools for genome analysis and drug discoveries.
- 5.1.2. Restraints
  - 5.1.2.1. Lack of reimbursement policies for genetic testing
- 5.1.3. Opportunities
  - 5.1.3.1. Ongoing advancements in molecular biology enzymes & kits & reagents
  - 5.1.3.2. Expansion of molecular biology enzymes & kits & reagents in agriculture biotechnology
- 5.1.4. Challenges
  - 5.1.4.1. Absence of high-end technology for storing genetic information
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter's Five Forces Analysis
- 5.5.1. Threat of New Entrants
- 5.5.2. Threat of Substitutes
- 5.5.3. Bargaining Power of Customers
- 5.5.4. Bargaining Power of Suppliers
- 5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework

6. Molecular Biology Enzymes & Kits & Reagents Market, by Type

6.1. Introduction
6.2. Enzymes
- 6.3.1. DNA Polymerases
- 6.3.2. Ligases
- 6.3.3. Restriction Enzymes
6.3. Kits
- 6.4.1. DNA Sequencing Kits
- 6.4.2. PCR Kits
- 6.4.3. RNA Extraction Kits
6.4. Reagents
- 6.5.1. Buffers
- 6.5.2. Dyes
- 6.5.3. Nucleotides
- 6.5.4. Primers
- 6.5.5. Stains

7. Molecular Biology Enzymes & Kits & Reagents Market, by Application

7.1. Introduction
7.2. Drug Discovery & Development
7.3. Epigenetics
7.4. Polymerase Chain Reaction
7.5. Sequencing

8. Molecular Biology Enzymes & Kits & Reagents Market, by End-User

8.1. Introduction
8.2. Academic & Research institutions
8.3. Diagnostic Centers
8.4. Hospitals
8.5. Pharma & Biotech Companies

9. Americas Molecular Biology Enzymes & Kits & Reagents Market

9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States

10. Asia-Pacific Molecular Biology Enzymes & Kits & Reagents Market

10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam

11. Europe, Middle East & Africa Molecular Biology Enzymes & Kits & Reagents Market

11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom

12. Competitive Landscape

12.1. FPNV Positioning Matrix
12.2. Market Share Analysis, By Key Player
12.3. Competitive Scenario Analysis, By Key Player

13. Competitive Portfolio

13.1. Key Company Profiles
- 13.1.1. ACROBiosystems Inc.
- 13.1.2. Agilent Technologies, Inc.
- 13.1.3. Bio Basic Inc.
- 13.1.4. Bio-Rad Laboratories, Inc.
- 13.1.5. F. Hoffmann-La Roche Ltd.
- 13.1.6. Fortis Life Sciences
- 13.1.7. Illumina, Inc.
- 13.1.8. Jena Bioscience GmbH
- 13.1.9. Krishgen Biosystems
- 13.1.10. LGC Limited
- 13.1.11. Merck KGaA
- 13.1.12. Miltenyi Biotec B.V. & Co. KG
- 13.1.13. Molecular Biology Resources, Inc.
- 13.1.14. New England Biolabs, Inc.
- 13.1.15. PerkinElmer Inc.
- 13.1.16. Promega Corporation
- 13.1.17. QIAGEN N.V.
- 13.1.18. Rockland Immunochemicals, Inc.
- 13.1.19. Sartorius AG
- 13.1.20. Takara Holdings Inc.
- 13.1.21. Thermo Fisher Scientific Inc.
- 13.1.22. Zymo Research Corporation
13.2. Key Product Portfolio

14. Appendix

14.1. Discussion Guide
14.2. License & Pricing